Viewing Study NCT05821192


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2025-12-24 @ 3:50 PM
Study NCT ID: NCT05821192
Status: UNKNOWN
Last Update Posted: 2023-04-20
First Post: 2023-03-23
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
Sponsor: Ou Bai, MD/PHD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module